Prosecution Insights
Last updated: August 18, 2026

Examiner: FLYNN, TIMOTHY LEE

Tech Center 3700 • Art Units: 3781 3783

This examiner grants 61% of resolved cases

Performance Statistics

61.0%
Allow Rate
-9.0% vs TC avg
105
Total Applications
+35.3%
Interview Lift
1276
Avg Prosecution Days
Based on 82 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
25.6%
§102 Novelty
62.4%
§103 Obviousness
10.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17439675 TREATMENT APPARATUS AND METHOD FOR EXTRACORPOREAL IMMUNOTOLERANCE ENHANCING BLOOD TREATMENT Non-Final OA Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V.
18364383 MODULAR SUCTION UNIT FOR A URINARY RELIEF SYSTEM Non-Final OA Rockwell Collins, Inc.
18075060 FLUID COLLECTING SHEATHS FOR ENDOSCOPIC DEVICES AND SYSTEMS Non-Final OA Covidien LP
17825909 DRUG THERAPY DELIVERY SYSTEMS AND METHODS Non-Final OA W. L. Gore & Associates, Inc.
18265552 SYSTEMS AND METHODS FOR WOUND DRESSING CONNECTOR WITH IMPROVED PRESSURE SENSING Final Rejection KCI Manufacturing Unlimited Company
17885680 Negative Pressure Therapy System and Methods Non-Final OA 3IVE Labs, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month